What is the intrinsic value of AGN.CN?
As of 2025-07-03, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is
0.05 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.06 CAD, the upside of Algernon Pharmaceuticals Inc is
-21.88%.
Is AGN.CN undervalued or overvalued?
Based on its market price of 0.06 CAD and our intrinsic valuation, Algernon Pharmaceuticals Inc (AGN.CN) is overvalued by 21.88%.
AGN.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.05 - 0.05 |
0.05 |
-21.88% |
| P/E |
0.02 - 0.04 |
0.03 |
-49.2% |
| DDM - Stable |
0.05 - 0.11 |
0.08 |
30.2% |
| DDM - Multi |
(0.08) - (0.16) |
(0.11) |
-276.4% |
AGN.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.72 |
| Beta |
-0.43 |
| Outstanding shares (mil) |
28.71 |
| Enterprise Value (mil) |
1.63 |
| Market risk premium |
5.10% |
| Cost of Equity |
11.55% |
| Cost of Debt |
5.00% |
| WACC |
7.62% |